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INTRODUCTION 
Evaluating the ocular health of every patient IS the standard of 
care in the optometric profession. Part of this standard is performing 
binocular indirect ophthalmoscopy and high plus ophthalmoscopy to 
evaluate the entire posterior segment with stereoscopic views : In 
order to achieve an adequate pupil diameter for viewing the 
structures of the fundus, diagnostic pharmaceutical agents are 
needed. The typical protocol is one drop of anesthetic followed by 
one drop of 2.5% phenylephrine and one drop of 1.0% tropicamide, 
with five minute intervals between each drop. This study will 
compare the above standard protocol to an experimental one drop 
mixture of 5% phenylephrine and 0.5% tropicamide. 
Phenylephrine is a direct acting alpha-adrenergic agonist 
contracts the iris dilator muscle. It causes little to no effect on 
which 
the 
In ciliary muscle, thus resulting in mydriasis with no cycloplegia. 
ophthalmic solutions, concentrations of 2.5% and 10% are 
commercially available. Studies have shown that the dose-response 
curves for phenylephrine indicate increasing mydriasis with 
concentrations up to 5%. Concentrations above 5% show little 
additional effect in mydriasis. Maximum dilation occurs within 45 to 
60 minutes depending on the concentration and number of drops 
used. Pre-dilation size of the pupil usually returns in 4 to 6 hours. 
When topical anesthetic precedes the instillation of phenylephrine 
the mydriatic effect is greater in amplitude, more rapid in onset, and 
longer lasting. (p439 B&J) Systemic adverse effects of 
phenylephrine include systemic hypertension, ventricular 
arrhythmia, tachycardia, and reflex bradycardia. However, the 
Bergerud and Saccomanno study evaluating the mydriatic effect of 
this same experimental mixture of 5% phenylephrine and 0.5% 
tropicamide, showed no statistically significant increase in pulse or 
blood pressure following its instillation. 
Tropicamide is an indirect acting anti-cholinergic agent. 
Tropicamide aids in mydriasis by relaxing the iris sphincter. It IS the 
preferred anti-cholinergic agent due to its ability to give an effective 
dilation in a short amount of time. Maximum dilation occurs in 15 to 
30 minutes with a duration of 4 to 6 hours. Its cycloplegic effects 
reaches its peak between 30 to 45 minutes, but quickly diminishes. 
Dose response curves show that tropicamide gives equal mydriatic 
effect in concentrations from 0.25% to 1.0%. It has also been shown 
that there is no significant difference in mydriatic latency, time 
difference between drop instillation and dilation, between 1.0% and 
0.5% solutions. Tropicamide is known as a safe mydriatic agent 
virtually free of systemic side effects. Together, phenylephrine and 
tropicamide have a compound effect in dilating the pupil. 
There are general considerations when applying topical 
ophthalmic drugs. One is the ability of the eye to retain 
approximately 10 microliters of fluid. Since the average dropper tip 
delivers 25 to 50 microliters per drop, the value of more than one 
drop is questionable. A second factor is the interval missing between 
drop instillations. To insure that the first drop is not t1ushed away 
by the second, or that the second drop is not diluted by the first, it is 
standard to wait five minutes between instillations. · Due to the above 
factors, we feel that the experimental one drop mixture of 5.0% 
phenylephrine and 0.5% tropicamide will be clinically effective and 
less time consuming in reaching mydriasis. 
In May of 1997, the Bergerud and Saccomanno determined the 
onset, peak, and duration of the experimental mydriatic solution. 
Results from that study showed a statistically significant increase m 
pupil diameter within ten minutes of instillation. The purpose of our 
study is to directly compare the onset and peak dilation between the 
experimental mixture and the standard protocol. 
SUBJECTS AND METHODS 
The experimental mixture was prepared by Lloyd Center 
Pharmacy of Portland, OR. This is the same pharmacy that prepared 
the mixture for the Bergerud and Saccomanno study. The topical 
mydriatic combination product was prepared by combining one part 
of 1.0% tropicamide (supplied by Professional Compounding Centers 
of America) and one part 10.0% phenylephrine (powder form 
supplied by Spectrum Chemical). The resultant preparation consisted 
of 0.5% tropicamide and 5.0% phenylephrine as active ingredients 
with benzalkonuim chloride 0.01% as the preservative. Purified 
water and 0.4% hydroxypropylmethy1cellulose were used as the 
vehicle; dibasic and monobasic sodium phosphate as buffers; and 
edetate disodium as the chelating agent. The solution was 
osmotically corrected with potassium chloride and sodium chloride. 
The pH of the solution was 5.1 and the viscosity was 1.3 to 1.5 
centipoise. The combination was supplied in standard eye dropper 
bottles with a drop size equal to 33 microliters. The solutions were 
stored at room temperature in amber bags to protect against 
ultraviolet radiation.2 
Pupil diameters were measured using an Essilor PRC 
pupillometer by Sola. The pupillometers were set at infinity and 
readings were taken monocularly. Subjects were instructed to look 
at the center fixation light. The measurements were then performed 
by lining up the vertical mire with one edge of the pupil, recording 
that number, and then lining up the same mire with the other edge 
of the pupil, and recording that measurement. The pupil size was 
determined by taking the difference between the two measurements. 
Prior to measuring subjects, each examiner took 10 measurements on 
one individual to determine intra-examiner reliability. These 
measurements were then analyzed for accuracy.put results here. 
Data collected for the purpose of this study was taken from 16 
subjects (32 eyes) in February of 1998. The subjects ranged in age 
from 22 to 40, with a mean age of 27. The group consisted of II 
males and 5 females. Subjects were grouped into a "blue" category 
(consisting of blue, grey, or green irides) or a "brown" category 
(consisting of brown or hazel irides). Seven subjects fell into the 
"blue" group and nine into the "brown" group. 
Prior to drop instillation each subject was asked a detailed case 
history. They were screened for medical history of hypertension, 
heart conditions, lung conditions, pregnancy, thyroid problems, 
diabetes, medications, and allergies. Each also had a slit lamp 
examination in which anterior chamber angles were measured with 
the Van Herick Method. All subjects met the criterion of having at 
least a grade three angle. Intraocular pressures were then measured 
by Goldmann applanation tonometry and all subjects were below 
21mm Hg. 
This study was conducted in a masked fashion. Those 
performing pupil size measurements did not know if subjects had 
received the experimental or standard drops. The subjects were 
randomly split into two different groups. One group received the 
experimental drop and the other received the standard two drop 
regimen. One drop of proparacaine was instilled in each subject's 
eyes, followed by one minute of punctal occlusion. Those in the 
standard group then received one drop of 1.0% tropicamide followed 
by one minute of puncta! occlusion. After that one minute, they 
received one drop of 2.5% phenylephrine again followed by one 
minute of puncta! occlusion. The experimental group received one 
drop of the mixture and followed with one minute of puncta! 
occlusion. After this puncta! occlusion, the time was noted and each 
subject went into the testing room where the pupils would be 
measured every ten minutes for the next 70-90 minutes. 
Variables such as overhead lighting and room conditions were 
kept constant for each subject's pupil readings by having the subject 
sit in the same place for each measurement. Each tester was 
assigned eight subjects on whom to measure the pupil diameter. 
All subjects participating in an associated study were measured for a 
period of 70 minutes. A11 others were measured for 90 minutes . 
Seven days later the same subjects returned and the 
experimental and standard groups were switched. Each subject 
followed the same group protocol as the week prior. To keep 
measurements constant the subjects were assigned the same seat 
and pupil examiner. 
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